{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:16:27Z","timestamp":1787728587658,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s13346-025-01797-w","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T13:14:39Z","timestamp":1737638079000},"page":"3185-3198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Construction of a thermosensitive gel based on hydroxypropyl-\u03b2-cyclodextrin\/meloxicam inclusion complexes for improving meloxicam solubility and prolonging drug retention time in the cornea"],"prefix":"10.1007","volume":"15","author":[{"given":"Lvyao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu\u2019e","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixia","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6881-9800","authenticated-orcid":false,"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"issue":"5","key":"1797_CR1","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.xcrm.2021.100277","volume":"23","author":"S Singh","year":"2021","unstructured":"Singh S, Singh PK, Jha A, Naik P, Joseph J, Giri S, Kumar A. Integrative metabolomics and transcriptomics identifies itaconate as an adjunct therapy to treat ocular bacterial infection. Cell Rep Med. 2021;23(5):875\u201384. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100277.","journal-title":"Cell Rep Med"},{"key":"1797_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2165\/00003495-200161020-00003","volume":"61","author":"PY Robert","year":"2001","unstructured":"Robert PY, Adenis JP. Comparative review of topical ophthalmic antibacterial preparations. Drugs. 2001;61:175\u201385. https:\/\/doi.org\/10.2165\/00003495-200161020-00003.","journal-title":"Drugs"},{"key":"1797_CR3","doi-asserted-by":"publisher","first-page":"114721","DOI":"10.1016\/j.addr.2023.114721","volume":"194","author":"C Wang","year":"2023","unstructured":"Wang C, Pang Y. Nano-based eye drop: topical and noninvasive therapy for ocular diseases. Adv Drug Deliver Rev. 2023;194:114721. https:\/\/doi.org\/10.1016\/j.addr.2023.114721.","journal-title":"Adv Drug Deliver Rev"},{"key":"1797_CR4","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.3389\/fimmu.2018.02283","volume":"9","author":"C Wei","year":"2018","unstructured":"Wei C, Wang Y, Ma L, Wang X, Chi H, Zhang S, Liu T, Li Z, Xiang D, Dong Y, Wu X, Shi W, Gao H. Rapamycin nano-micelle ophthalmic solution reduces corneal allograft rejection by potentiating myeloid-derived suppressor cells\u2019 function. Front Immunol. 2018;9:2283. https:\/\/doi.org\/10.3389\/fimmu.2018.02283.","journal-title":"Front Immunol"},{"issue":"11","key":"1797_CR5","doi-asserted-by":"publisher","first-page":"2100202","DOI":"10.1002\/mabi.202100202","volume":"21","author":"F Wang","year":"2021","unstructured":"Wang F, Song Y, Huang J, Wu B, Wang Y, Pang Y, Zhang W, Zhu Z, Ma F, Wang X, Zhang X. Lollipop-inspired multilayered drug delivery hydrogel for dual effective, long-term, and NIR-defined glaucoma treatment. Macromol Biosci. 2021;21(11):2100202. https:\/\/doi.org\/10.1002\/mabi.202100202.","journal-title":"Macromol Biosci"},{"issue":"12","key":"1797_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s11095-018-2513-3","volume":"35","author":"Q Bao","year":"2018","unstructured":"Bao Q, Burgess DJ. Perspectives on physicochemical and in vitro profiling of ophthalmic ointments. Pharm Res. 2018;35(12):234. https:\/\/doi.org\/10.1007\/s11095-018-2513-3.","journal-title":"Pharm Res"},{"issue":"1","key":"1797_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijpharm.2017.03.039","volume":"523","author":"Q Bao","year":"2017","unstructured":"Bao Q, Jog R, Shen J, Newman B, Wang Y, Choi S, Burgess DJ. Physicochemical attributes and dissolution testing of ophthalmic ointments. Int J Pharm. 2017;523(1):310\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.03.039.","journal-title":"Int J Pharm"},{"key":"1797_CR8","doi-asserted-by":"publisher","first-page":"119495","DOI":"10.1016\/j.ijpharm.2020.119495","volume":"586","author":"A Vo","year":"2020","unstructured":"Vo A, Feng X, Patel D, Mohammad A, Kozak D, Choi S, Ashraf M, Xu X. Factors affecting the particle size distribution and rheology of brinzolamide ophthalmic suspensions. Int J Pharm. 2020;586:119495. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119495.","journal-title":"Int J Pharm"},{"issue":"1","key":"1797_CR9","doi-asserted-by":"publisher","first-page":"2372279","DOI":"10.1080\/10717544.2024.2372279","volume":"31","author":"K Krzeminska","year":"2024","unstructured":"Krzeminska K, Sznitowska M, Wroblewska M, Wolska E, Winnicka K. Suspensions of antibiotics in self-emulsifying oils as a novel approach to formulate eye drops with substances which undergo hydrolysis in aqueous environment. Drug Deliv. 2024;31(1):2372279. https:\/\/doi.org\/10.1080\/10717544.2024.2372279.","journal-title":"Drug Deliv"},{"issue":"2","key":"1797_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1208\/s12248-008-9024-9","volume":"10","author":"M Ahuja","year":"2008","unstructured":"Ahuja M, Dhake AS, Sharma SK, Majumdar DK. Topical ocular delivery of NSAIDs. AAPS J. 2008;10(2):229\u2013. https:\/\/doi.org\/10.1208\/s12248-008-9024-9. \u200941.","journal-title":"AAPS J"},{"key":"1797_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.addr.2019.02.004","volume":"151","author":"ML Scherholz","year":"2019","unstructured":"Scherholz ML, Schlesinger N, Androulakis IP. Chronopharmacology of glucocorticoids. Adv Drug Deliver Rev. 2019;151:245\u201361. https:\/\/doi.org\/10.1016\/j.addr.2019.02.004.","journal-title":"Adv Drug Deliver Rev"},{"issue":"2","key":"1797_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000068563","volume":"217","author":"R Schalnus","year":"2003","unstructured":"Schalnus R. Topical nonsteroidal anti-inflammatory therapy in ophthalmology. Ophthalmologica. 2003;217(2):89\u201398. https:\/\/doi.org\/10.1159\/000068563.","journal-title":"Ophthalmologica"},{"key":"1797_CR13","doi-asserted-by":"publisher","first-page":"106578","DOI":"10.1016\/j.prostaglins.2021.106578","volume":"156","author":"C Chen","year":"2021","unstructured":"Chen C, Wang C, Zhou X, Xu L, Chen H, Qian K, Jia B, Su G, Fu J. Nonsteroidal anti-inflammatory drugs for retinal neurodegenerative diseases. Prostag Other Lipid Mediat. 2021;156:106578. https:\/\/doi.org\/10.1016\/j.prostaglins.2021.106578.","journal-title":"Prostag Other Lipid Mediat"},{"issue":"9","key":"1797_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/intimm\/dxz021","volume":"31","author":"K Tsuge","year":"2019","unstructured":"Tsuge K, Inazumi T, Shimamoto A, Sugimoto Y. Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases. Int Immunol. 2019;31(9):597\u2013606. https:\/\/doi.org\/10.1093\/intimm\/dxz021.","journal-title":"Int Immunol"},{"issue":"1","key":"1797_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpba.2004.01.003","volume":"35","author":"NB Naidu","year":"2004","unstructured":"Naidu NB, Chowdary KPR, Murthy KVR, Satyanarayana V, Hayman AR, Becket G. Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems. J Pharmaceut Biomed Anal. 2004;35(1):75\u201386. https:\/\/doi.org\/10.1016\/j.jpba.2004.01.003.","journal-title":"J Pharmaceut Biomed Anal"},{"issue":"9","key":"1797_CR16","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3390\/molecules22091507","volume":"22","author":"SD Oniga","year":"2017","unstructured":"Oniga SD, Pacureanu L, Stoica CI, Palage MD, Cr\u0103ciun A, Rusu LR, Crisan E-L, Araniciu C. COX inhibition profile and molecular docking studies of some 2-(trimethoxyphenyl)-thiazoles. Molecules. 2017;22(9):1507. https:\/\/doi.org\/10.3390\/molecules22091507.","journal-title":"Molecules"},{"key":"1797_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejps.2016.05.031","volume":"95","author":"M Horv\u00e1th","year":"2016","unstructured":"Horv\u00e1th M, Ambrus R, V\u00f6lgyi G, Budai-Szucs M, M\u00e1rki A, Sipos P, Bartos C, Seres AB, Sztojkov-Ivanov A, Tak\u00e1cs-Nov\u00e1k K, Cs\u00e1nyi E, G\u00e1sp\u00e1r R, Szab\u00f3-R\u00e9v\u00e9sz P. Effect of solubility enhancement on nasal absorption of meloxicam. Eur J Pharm Sci. 2016;95:96\u2013102. https:\/\/doi.org\/10.1016\/j.ejps.2016.05.031.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"1797_CR18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10904-019-01230-z","volume":"30","author":"F Monteforte","year":"2020","unstructured":"Monteforte F, Bruni G, Quinzeni I, Friuli V, Maggi L, Capsoni D, Bini M. Meloxicam-LDH hybrid compound: a successful strategy to improve solubility. J Inorg Organomet P. 2020;30(3):637\u201348. https:\/\/doi.org\/10.1007\/s10904-019-01230-z.","journal-title":"J Inorg Organomet P"},{"issue":"12","key":"1797_CR19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/00914037.2020.1765359","volume":"70","author":"SSH Abadi","year":"2021","unstructured":"Abadi SSH, Gangadharappa HV, Balamuralidhara V. Development of colon-specific mucoadhesive meloxicam microspheres for the treatment of CFA-induced arthritis in rats. Int J Polym Mater. 2021;70(12):849\u201369. https:\/\/doi.org\/10.1080\/00914037.2020.1765359.","journal-title":"Int J Polym Mater"},{"key":"1797_CR20","doi-asserted-by":"publisher","first-page":"115400","DOI":"10.1016\/j.molliq.2021.115400","volume":"328","author":"E Rahimpour","year":"2021","unstructured":"Rahimpour E, Jouyban A. Utilizing Abraham and Hansen solvation parameters for solubility prediction of meloxicam in cosolvency systems. J Mol Liq. 2021;328:115400. https:\/\/doi.org\/10.1016\/j.molliq.2021.115400.","journal-title":"J Mol Liq"},{"issue":"3","key":"1797_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3390\/biom11030361","volume":"11","author":"GM Miranda","year":"2021","unstructured":"Miranda GM, Santos VORe, Bessa JR, Teles YCF, Yahouedehou SCMA, Goncalves MS, Ribeiro-Filho J. Inclusion complexes of non-steroidal anti-inflammatory drugs with cyclodextrins: a systematic review. Biomolecules. 2021;11(3):361. https:\/\/doi.org\/10.3390\/biom11030361.","journal-title":"Biomolecules"},{"issue":"4","key":"1797_CR22","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ajps.2016.02.009","volume":"11","author":"GOK Loh","year":"2016","unstructured":"Loh GOK, Tan YTF, Peh K-K. Enhancement of norfloxacin solubility via inclusion complexation with \u03b2-cyclodextrin and its derivative hydroxypropyl-\u03b2-cyclodextrin. Asian J Pharm Sci. 2016;11(4):536\u201346. https:\/\/doi.org\/10.1016\/j.ajps.2016.02.009.","journal-title":"Asian J Pharm Sci"},{"key":"1797_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2020.01.057","volume":"321","author":"C Jumelle","year":"2020","unstructured":"Jumelle C, Gholizadeh S, Annabi N, Dana R. Advances and limitations of drug delivery systems formulated as eye drops. J Control Release. 2020;321:1\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2020.01.057.","journal-title":"J Control Release"},{"issue":"8","key":"1797_CR24","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/polym13081340","volume":"13","author":"M Pandey","year":"2021","unstructured":"Pandey M, Choudhury H, Abd Aziz AB, Bhattamisra SK, Gorain B, Su JST, Tan CL, Chin WY, Yip KY. Potential of stimuli-responsive in situ gel system for sustained ocular drug delivery: recent progress and contemporary research. Polymers. 2021;13(8):1340. https:\/\/doi.org\/10.3390\/polym13081340.","journal-title":"Polymers"},{"key":"1797_CR25","doi-asserted-by":"publisher","unstructured":"Sapino S, Chirio D, Peira E, Rubio EA, Brunella V, Jadhav SA, Chindamo G, Gallarate M. Ocular drug delivery: a special focus on the thermosensitive approach. Nanomaterials. 2019;9(6). https:\/\/doi.org\/10.3390\/nano9060884.","DOI":"10.3390\/nano9060884"},{"issue":"5","key":"1797_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ajps.2019.09.003","volume":"15","author":"H Elmotasem","year":"2020","unstructured":"Elmotasem H, Awad GEA. A stepwise optimization strategy to formulate in situ gelling formulations comprising fluconazole-hydroxypropyl-beta-cyclodextrin complex loaded niosomal vesicles and Eudragit nanoparticles for enhanced antifungal activity and prolonged ocular delivery. Asian J Pharm Sci. 2020;15(5):617\u201336. https:\/\/doi.org\/10.1016\/j.ajps.2019.09.003.","journal-title":"Asian J Pharm Sci"},{"key":"1797_CR27","doi-asserted-by":"publisher","first-page":"119577","DOI":"10.1016\/j.ijpharm.2020.119577","volume":"586","author":"PM Campos","year":"2020","unstructured":"Campos PM, Petrilli R, Lopez RFV. The prominence of the dosage form design to treat ocular diseases. Int J Pharm. 2020;586:119577. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119577.","journal-title":"Int J Pharm"},{"issue":"2","key":"1797_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1039\/c3tb21016b","volume":"2","author":"A Vashist","year":"2014","unstructured":"Vashist A, Vashist A, Gupta YK, Ahmad S. Recent advances in hydrogel based drug delivery systems for the human body. J Mater Chem B. 2014;2(2):147\u201366. https:\/\/doi.org\/10.1039\/c3tb21016b.","journal-title":"J Mater Chem B"},{"issue":"1","key":"1797_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajps.2018.04.008","volume":"14","author":"YM Wu","year":"2019","unstructured":"Wu YM, Liu YY, Li XY, Kebebe D, Zhang B, Ren J, Lu J, Li JW, Du SY, Liu ZD. Research progress of in-situ gelling ophthalmic drug delivery system. Asian J Pharm Sci. 2019;14(1):1\u201315. https:\/\/doi.org\/10.1016\/j.ajps.2018.04.008.","journal-title":"Asian J Pharm Sci"},{"issue":"16","key":"1797_CR30","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.3390\/ma14164522","volume":"14","author":"YB Chen","year":"2021","unstructured":"Chen YB, Lee JH, Meng MY, Cui NY, Dai CY, Jia Q, Lee ES, Jiang HB. An overview on thermosensitive oral gel based on Poloxamer 407. Materials. 2021;14(16):4522. https:\/\/doi.org\/10.3390\/ma14164522.","journal-title":"Materials"},{"issue":"3","key":"1797_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ejpb.2007.03.022","volume":"66","author":"DA Chiappetta","year":"2007","unstructured":"Chiappetta DA, Sosnik A. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm. 2007;66(3):303\u201317. https:\/\/doi.org\/10.1016\/j.ejpb.2007.03.022.","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"1797_CR32","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1517\/17425247.2013.796360","volume":"10","author":"H Almeida","year":"2013","unstructured":"Almeida H, Amaral MH, Lobao P, Sousa Lobo JM. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview. Expert Opin Drug Deliv. 2013;10(9):1223\u201337. https:\/\/doi.org\/10.1517\/17425247.2013.796360.","journal-title":"Expert Opin Drug Deliv"},{"key":"1797_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.addr.2017.12.017","volume":"126","author":"AA Al-Kinani","year":"2018","unstructured":"Al-Kinani AA, Zidan G, Elsaid N, Seyfoddin A, Alani AWG, Alany RG. Ophthalmic gels: past, present and future. Adv Drug Deliver Rev. 2018;126:113\u201326. https:\/\/doi.org\/10.1016\/j.addr.2017.12.017.","journal-title":"Adv Drug Deliver Rev"},{"key":"1797_CR34","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.2147\/ijn.S60270","volume":"9","author":"J Lou","year":"2014","unstructured":"Lou J, Hu W, Tian R, Zhang H, Jia Y, Zhang J, Zhang L. Optimization and evaluation of a thermoresponsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticles. Int J Nanomed. 2014;9:2517\u201325. https:\/\/doi.org\/10.2147\/ijn.S60270.","journal-title":"Int J Nanomed"},{"issue":"2","key":"1797_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/pharmaceutics13020207","volume":"13","author":"P Agarwal","year":"2021","unstructured":"Agarwal P, Craig JP, Rupenthal ID. Formulation considerations for the management of dry eye disease. Pharmaceutics. 2021;13(2):207. https:\/\/doi.org\/10.3390\/pharmaceutics13020207.","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"1797_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijpharm.2011.03.054","volume":"411","author":"R Asasutjarit","year":"2011","unstructured":"Asasutjarit R, Thanasanchokpibull S, Fuongfuchat A, Veeranondha S. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels. Int J Pharm. 2011;411(1\u20132):128\u201335. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.03.054.","journal-title":"Int J Pharm"},{"issue":"1","key":"1797_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/10717544.2017.1413448","volume":"25","author":"Q Wang","year":"2017","unstructured":"Wang Q, Sun C, Xu B, Tu J, Shen Y. Synthesis, physicochemical properties and ocular pharmacokinetics of thermosensitive in situ hydrogels for ganciclovir in cytomegalovirus retinitis treatment. Drug Delivery. 2017;25(1):59\u201369. https:\/\/doi.org\/10.1080\/10717544.2017.1413448.","journal-title":"Drug Delivery"},{"key":"1797_CR38","doi-asserted-by":"publisher","first-page":"111445","DOI":"10.1016\/j.msec.2020.111445","volume":"119","author":"Y Wen","year":"2021","unstructured":"Wen Y, Jia H, Mo Z, Zheng K, Chen S, Ding Y, Zhang Y, Wen Y, Xie Q, Qiu J, Wu H, Ni Q, Ban J, Lu Z, Chen Y. Cross-linked thermosensitive nanohydrogels for ocular drug delivery with a prolonged residence time and enhanced bioavailability. Mater Sci Eng C. 2021;119:111445. https:\/\/doi.org\/10.1016\/j.msec.2020.111445.","journal-title":"Mater Sci Eng C"},{"issue":"7","key":"1797_CR39","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3390\/pharmaceutics13070994","volume":"13","author":"TA Al Hujran","year":"2021","unstructured":"Al Hujran TA, Magharbeh MK, Al-Gharabli S, Haddadin RR, Al Soub MN, Tawfeek HM. Studying the complex formation of sulfonatocalix 4 naphthalene and meloxicam towards enhancing its solubility and dissolution performance. Pharmaceutics. 2021;13(7):994. https:\/\/doi.org\/10.3390\/pharmaceutics13070994.","journal-title":"Pharmaceutics"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01797-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01797-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01797-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T12:11:54Z","timestamp":1755087114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01797-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1797"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01797-w","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"14 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Authors agree and have given consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}